Trovagene Inc Business Update Conference Call Transcript
Welcome to the Trovagene conference call. (Operator Instructions) As a reminder, this conference is being recorded today, June 7.
I would now like to turn the conference over to Vicki Kelemen, Vice President, Investor Relations and Clinical Development. Ms. Kelemen, please go ahead.
Good morning, and thank you all for participating in today's business update conference call. Joining me are Dr. Thomas Adams, Chief Executive Officer and Chairman of Trovagene; and Dr. Mark Erlander, our Chief Scientific Officer.
During today's call, we're going to review the status of our Onvansertib clinical development program, key preliminary data, a recent collaboration announcement and future milestones. At the conclusion of our prepared remarks, we will open the call for questions.
Before we begin, we advise that certain remarks that are made during this call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
